Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6316 to 6330 of 8930 results

  1. Major changes to type 2 diabetes treatment could save thousands of lives

    New guidance means millions of people will get access to medicines that protect the heart and kidneys, while NHS savings of £560 million from using generic dapagliflozin can be reinvested elsewhere in NHS care.

  2. First treatment for vitiligo recommended by NICE for NHS use, bringing hope to over 80,000 people

    For the first time, NICE has recommended a medicine that effectively treats the underlying cause of devastating skin condition vitiligo

  3. New hope for people with breathing condition, COPD, as NICE approves innovative treatment

    Breakthrough therapy reduces flare-ups by almost a third and could ease pressure on NHS hospitals.

  4. Thousands could benefit from new take-at-home treatment for advanced prostate cancer

    NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment.

  5. Online help programme recommended for people with eating disorders

    An online therapy programme can be used to help people aged 16 and over with eating disorders whilst they wait for specialist NHS treatment, an independent NICE has said.

  6. Thousands living with lupus offered hope from twice-yearly infusion

    NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus nephritis.

  7. Hidden spine fractures could be spotted earlier after NICE recommendation

    NICE is recommending that quick spine checks are added to routine bone scans to help spot hidden fractures earlier and prevent serious complications.

  8. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

  9. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

  10. Diabetes: statins for primary prevention of CVD (T2DM and 10% risk) (IND182)

    This guidance has been updated and replaced by NICE indicator 274.

  11. Atrial fibrillation: pulse rhythm assessment in people at risk (IND168)

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

  12. Weight management: BMI calculation in preceding 5 years (IND167)

    This indicator has been withdrawn following discussions with the National Screening Committee.

  13. Diabetes: T1DM and statins (IND166)

    This guidance has been updated and replaced by NICE indicator 277.

  14. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator has been updated and replaced by NICE indicator 320.